KAIROS PHARMA, LTD. Investment Income, Net
KAIROS PHARMA, LTD. (KAPA) reported Investment Income, Net of $29.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-08-12
- KAIROS PHARMA, LTD. investment income, net for the quarter ending 2026-06-30 was $29.00K, a 14.71% decline year-over-year.
- KAIROS PHARMA, LTD. investment income, net for the quarter ending 2026-03-31 was $36.00K, a 800.00% increase year-over-year.
- KAIROS PHARMA, LTD. investment income, net for the quarter ending 2025-12-31 was $50.00K.
- KAIROS PHARMA, LTD. investment income, net for the quarter ending 2025-09-30 was $37.00K.
- KAIROS PHARMA, LTD. investment income, net for fiscal 2025 was $125.00K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.00K 10-Q · filed 2026-08-12 | $65.00K 10-Q · filed 2026-08-12 | $115.00K derived: sum of 3 quarters · filed 2026-08-12 | $152.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $36.00K 10-Q · filed 2026-05-13 | $86.00K derived: sum of 2 quarters · filed 2026-05-13 | $123.00K derived: sum of 3 quarters · filed 2026-05-13 | $157.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $87.00K derived: sum of 2 quarters · filed 2026-03-31 | $121.00K derived: sum of 3 quarters · filed 2026-08-12 | $125.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $37.00K 10-Q · filed 2025-11-14 | $71.00K derived: sum of 2 quarters · filed 2026-08-12 | $75.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $34.00K 10-Q · filed 2026-08-12 | $38.00K 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |